Intermolecular interactions between peptidic and nonpeptidic agonists and the third extracellular loop of the cholecystokinin 1 receptor

Journal of Medicinal Chemistry

Volumn 46, Issue 16, 2003, Pages 3476-3482

  Giragossian, Craig ^a   Sugg, Elizabeth E ^b   Szewczyk, Jerzy R ^b   Mierke, Dale F ^a  

^a BROWN UNIVERSITY   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (1H INDAZOL 3 YLMETHYL) 3 METHYL 5 PYRIDIN 3 YL 1,5 BENZODIAZEPINE; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ RECEPTOR; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; CHOLECYSTOKININ RECEPTOR STIMULATING AGENT; DEVAZEPIDE; GI 0122; GI 5269; N ISOPROPYL N (4 METHOXYPHENYL)ACETAMIDE DERIVATIVE; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

AQUEOUS SOLUTION; ARTICLE; COMPUTER SIMULATION; DRUG BINDING SITE; DRUG RECEPTOR BINDING; LIGAND BINDING; MOLECULAR INTERACTION; MUTAGENESIS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUCLEAR OVERHAUSER EFFECT; PROTEIN DOMAIN; STRUCTURE ACTIVITY RELATION;

BENZODIAZEPINONES; BINDING SITES; COMPUTER SIMULATION; DEVAZEPIDE; HUMANS; ISOMERISM; LIGANDS; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; MUTATION; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; RECEPTOR, CHOLECYSTOKININ A; RECEPTORS, CHOLECYSTOKININ; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0041842676     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm030144z     Document Type: Article

References (49)

1. Noble, F.; Roques, B. P. CCK-B receptor: chemistry, molecular biology, biochemistry and pharmacology. Prog. Neurobiol. 1999, 58, 349-379.
2. Wank, S. A. G protein-coupled receptors in gastrointestinal physiology. I. CCK receptors: an exemplary family. Am. J. Physiol. 1998, 274, G607-613.
3. Rehfeld, J. F.; van Solinge, W. W. The tumor biology of gastrin and cholecystokinin. Adv. Cancer Res. 1994, 63, 295-347.
4. Chang, R. S.; Lotti, V. J.; Monaghan, R. L.; Birnbaum, J.; Stapley, E. O.; Goetz, M. A.; Albers-Schonberg, G.; Patchett, A. A.; Liesch, J. M.; Hensens, O. D.; et al. A potent nonpeptide cholecystokinin antagonist selective for peripheral tissues isolated from Aspergillus alliaceus. Science 1985, 230, 177-179.
5. Shiosaki, K.; Lin, C. W.; Kopecka, H.; Bianchi, B.; Miller, T.; Stashko, M.; Witte, D. Minor structural differences in Boc-CCK-4 derivatives dictate affinity and selectivity for CCK-A and CCK-B receptors. J. Med. Chem. 1997, 40, 1169-1172.
6. Sugg, E. E.; Kimery, M. J.; Ding, J. M.; Kenakin, D. C.; Miller, L. J.; Queen, K. L.; Rimele, T. J. CCK-A receptor selective antagonists derived from the CCK-A receptor selective tetrapeptide agonist Boc-Trp-Lys(Tac)-Asp-MePhe-NH2 (A-71623). J. Med. Chem. 1995, 38, 207-211.
7. Shiosaki, K.; Lin, C. W.; Kopecka, H.; Tufano, M. D.; Bianchi, B. R.; Miller, T. R.; Witte, D. G.; Nadzan, A. M. Boc-CCK-4 derivatives containing side-chain ureas as potent and selective CCK-a receptor agonists. J. Med. Chem. 1991, 34, 2837-2842.
8. Lin, C. W.; Shiosaki, K.; Miller, T. R.; Witte, D. G.; Bianchi, B. R.; Wolfram, C. A.; Kopecka, H.; Craig, R.; Wagenaar, F.; Nadzan, A. M. Characterization of two novel cholecystokinin tetrapeptide (30-33) analogues, A-71623 and A-70874, that exhibit high potency and selectivity for cholecystokinin-A receptors. Mol Pharmacol 1991, 39, 346-351.
9. Shiosaki, K.; Lin, C. W.; Kopecka, H.; Craig, R.; Wagenaar, F. L.; Bianchi, B.; Miller, T.; Witte, D.; Nadzan, A. M. Development of CCK-tetrapeptide analogues as potent and selective CCK-A receptor agonists. J. Med. Chem. 1990, 33, 2950-2952.
10. Bock, M. G.; DiPardo, R. M.; Evans, B. E.; Rittle, K. E.; Veber, D. F.; Freidinger, R. M.; Chang, R. S.; Lotti, V. J. Cholecystokinin antagonists. Synthesis and biological evaluation of 4-substituted 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepines. J. Med. Chem. 1988, 31, 176-181.
11. Evans, B. E.; Rittle, K. E.; Bock, M. G.; DiPardo, R. M.; Freidinger, R. M.; Whitter, W. L.; Lundell, G. F.; Veber, D. F.; Anderson, P. S.; Chang, R. S.; et al. Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists. J. Med. Chem. 1988, 31, 2235-2246.
12. Evans, B. E.; Rittle, K. E.; Bock, M. G.; DiPardo, R. M.; Freidinger, R. M.; Whitter, W. L.; Gould, N. P.; Lundell, G. F.; Homnick, C. F.; Veber, D. F.; et al. Design of nonpeptidal ligands for a peptide receptor: cholecystokinin antagonists. J. Med. Chem. 1987, 30, 1229-1239.
13. Bock, M. G.; DiPardo, R. M.; Rittle, K. E.; Evans, B. E.; Freidinger, R. M.; Veber, D. F.; Chang, R. S.; Chen, T. B.; Keegan, M. E.; Lotti, V. J. Cholecystokinin antagonists. Synthesis of asperlicin analogues with improved potency and water solubility. J. Med. Chem. 1986, 29, 1941-1945.
14. Evans, B. E.; Bock, M. G.; Rittle, K. E.; DiPardo, R. M.; Whitter, W. L.; Veber, D. F.; Anderson, P. S.; Freidinger, R. M. Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokinin. Proc Natl Acad Sci U.S.A. 1986, 83, 4918-4922.
15. Sherrill, R. G.; Berman, J. M.; Birkemo, L.; Croom, D. K.; Dezube, M.; Ervin, G. N.; Grizzle, M. K.; James, M. K.; Johnson, M. F.; Queen, K. L.; Rimele, T. J.; Vanmiddlesworth, F.; Sugg, E. E. 1,4-Benzodiazepine peripheral cholecystokinin (CCK-A) receptor agonists. Bioorg. Med. Chem. Lett. 2001, 11, 1145-1148.
16. Willson, T. M.; Henke, B. R.; Momtahen, T. M.; Myers, P. L.; Sugg, E. E.; Unwalla, R. J.; Croom, D. K.; Dougherty, R. W.; Grizzle, M. K.; Johnson, M. F.; Queen, K. L.; Rimele, T. J.; Yingling, J. D.; James, M. K. 3-[2-(N-phenylacetamide)]-1,5-benzodiazepines: orally active, binding selective CCK-A agonists. J. Med. Chem. 1996, 39, 3030-3034.
17. Henke, B. R.; Willson, T. M.; Sugg, E. E.; Croom, D. K.; Dougherty, R. W., Jr.; Queen, K. L.; Birkemo, L. S.; Ervin, G. N.; Grizzle, M. K.; Johnson, M. F.; James, M. K. 3-(1H-indazol-3-ylmethyl)-1,5-benzodiazepines: CCK-A agonists that demonstrate oral activity as satiety agents. J. Med. Chem. 1996, 39, 2655-2658.
18. Aquino, C. J.; Armour, D. R.; Berman, J. M.; Birkemo, L. S.; Carr, R. A.; Croom, D. K.; Dezube, M.; Dougherty, R. W., Jr.; Ervin, G. N.; Grizzle, M. K.; Head, J. E.; Hirst, G. C.; James, M. K.; Johnson, M. F.; Miller, L. J.; Queen, K. L.; Rimele, T. J.; Smith, D. N.; Sugg, E. E. Discovery of 1,5-benzodiazepines with peripheral cholecystokinin (CCK-A) receptor agonist activity. 1. Optimization of the agonist "trigger". J Med Chem 1996, 39, 562-569.
19. West, A. P., Jr.; Llamas, L. L.; Snow, P. M.; Benzer, S.; Bjorkman, P. J. Crystal structure of the ectodomain of Methuselah, a Drosophila G protein-coupled receptor associated with extended lifespan. Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 3744-3749.
20. Kunishima, N.; Shimada, Y.; Tsuji, Y.; Sato, T.; Yamamoto, M.; Kumasaka, T.; Nakanishi, S.; Jingami, H.; Morikawa, K. Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor. Nature 2000, 407, 971-977.
21. Yeagle, P. L.; Albert, A. D. Use of nuclear magnetic resonance to study the three-dimensional structure of rhodopsin. Methods Enzymol. 2002, 343, 223-231.
22. Mierke, D. F.; Giragossian, C. Peptide hormone binding to G-protein-coupled receptors: structural characterization via NMR techniques. Med. Res. Rev. 2001, 21, 450-471.
23. Pellegrini, M.; Mierke, D. F. The molecular complex of cholecystokinin-8 and N-terminus of the cholecystokinin A receptor by NMR spectroscopy. Biochemistry 1999, 38, 14775-14783.
24. Giragossian, C.; Mierke, D. F. Intermolecular interactions between cholecystokinin-8 and the third extracellular loop of the cholecystokinin A receptor. Biochemistry 2001, 40, 3804-3809.
25. Giragossian, C.; Mierke, D. F. Intermolecular interactions between cholecystokinin-8 and the third extracellular loop of the cholecystokinin-2 receptor. Biochemistry 2002, 41, 4560-4566.
26. Giragossian, C.; Pellegrini, M.; Mierke, D. F. NMR studies of CCK-8/CCK1 complex support membrane-associated pathway for ligand-receptor interaction. Can. J. Physiol. Pharmacol. 2002, 80, 383-387.
27. Bovey, F. A. High-Resolution NMR of Macromolecules; Academic Press: New York, 1972.
28. Kessler, H. Peptide Conformation: Conformation and biological activity of cyclic peptides. Angew. Chem., Int. Ed. Engl. 1982, 21, 512-523.
29. Giragossian, C.; Stone, S.; Papini, A. M.; Moroder, L.; Mierke, D. F. Conformational and molecular modeling studies of sulfated cholecystokinin-15. Biochem. Biophys. Res. Commun. 2002, 293, 1053-1059.
30. Ursini, A.; Capelli, A. M.; Carr, R. A.; Cassara, P.; Corsi, M.; Curcuruto, O.; Curotto, G.; Dal Cin, M.; Davalli, S.; Donati, D.; Feriani, A.; Finch, H.; Finizia, G.; Gaviraghi, G.; Marien, M.; Pentassuglia, G.; Polinelli, S.; Ratti, E.; Reggiani, A.; Tarzia, G.; Tedesco, G.; Tranquillini, M. E.; Trist, D. G.; Van Amsterdam, F. T. Synthesis and SAR of new 5-phenyl-3-ureido-1,5-benzodiazepines as cholecystokinin-B receptor antagonists. J. Med. Chem. 2000, 43, 3596-3613.
31. Gigoux, V.; Escrieut, C.; Fehrentz, J. A.; Poirot, S.; Maigret, B.; Moroder, L.; Gully, D.; Martinez, J.; Vaysse, N.; Fourmy, D. Arginine 336 and asparagine 333 of the human cholecystokinin-A receptor binding site interact with the penultimate aspartic acid and the C-terminal amide of cholecystokinin. J. Biol. Chem. 1999, 274, 20457-20464.
32. Kennedy, K.; Gigoux, V.; Escrieut, C.; Maigret, B.; Martinez, J.; Moroder, L.; Frehel, D.; Gully, D.; Vaysse, N.; Fourmy, D. Identification of two amino acids of the human cholecystokinin-A receptor that interact with the N-terminal moiety of cholecystokinin. J. Biol. Chem. 1997, 272, 2920-2926.
33. Townsend-Nicholson, A.; Schofield, P. R. A threonine residue in the seventh transmembrane domain of the human A1 adenosine receptor mediates specific agonist binding. J. Biol. Chem. 1994, 269, 2373-2376.
34. Sachais, B. S.; Snider, R. M.; Lowe, J. A., 3rd; Krause, J. E. Molecular basis for the species selectivity of the substance P antagonist CP-96,345. J. Biol. Chem. 1993, 268, 2319-2323.
35. Suryanarayana, S.; Daunt, D. A.; Von Zastrow, M.; Kobilka, B. K. A point mutation in the seventh hydrophobic domain of the alpha 2 adrenergic receptor increases its affinity for a family of beta receptor antagonists. J. Biol. Chem. 1991, 266, 15488-15492.
36. Jagerschmidt, A.; Guillaume-Rousselet, N.; Vikland, M. L.; Goudreau, N.; Maigret, B.; Roques, B. P. His381 of the rat CCKB receptor is essential for CCKB versus CCKA receptor antagonist selectivity. Eur. J. Pharmacol. 1996, 296, 97-106.
37. Kopin, A. S.; McBride, E. W.; Quinn, S. M.; Kolakowski, L. F., Jr.; Beinborn, M. The role of the cholecystokinin-B/gastrin receptor transmembrane domains in determining affinity for subtype-selective ligands. J. Biol. Chem. 1995, 270, 5019-5023.
38. Mantamadiotis, T.; Baldwin, G. S. The seventh transmembrane domain of gastrin/CCK receptors contributes to non-peptide antagonist binding. Biochem. Biophys. Res. Commun. 1994, 201, 1382-1389.
39. Beinborn, M.; Lee, Y. M.; McBride, E. W.; Quinn, S. M.; Kopin, A. S. A single amino acid of the cholecystokinin-B/gastrin receptor determines specificity for non-peptide antagonists. Nature 1993, 362, 348-350.
40. Kennedy, K.; Escrieut, C.; Dufresne, M.; Clerc, P.; Vaysse, N.; Fourmy, D. Identification of a region of the N-terminal of the human CCKA receptor essential for the high affinity interaction with agonist CCK. Biochem. Biophys. Res. Commun. 1995, 213, 845-852.
41. Gigoux, V.; Maigret, B.; Escrieut, C.; Silvente-Poirot, S.; Bouisson, M.; Fehrentz, J. A.; Moroder, L.; Gully, D.; Martinez, J.; Vaysse, N.; Fourmy, A. D. Arginine 197 of the cholecystokinin-A receptor binding site interacts with the sulfate of the peptide agonist cholecystokinin. Protein Sci. 1999, 8, 2347-2354.
42. States, D. J.; Haberkorn, R. A.; Ruben, D. J. A Two-Dimensional Nuclear Overhauser Experiment with Pure Absorption Phase in Four Quadrants. J. Magn. Reson. 1982, 48, 286-292.
43. Kim, Y.; Prestegard, J. H. Measurement of Vicinal Couplings from Cross-Peaks in COSY Spectra. J. Magn. Reson. 1989, 84, 9-13.
44. Delaglio, F.; Grzesiek, S.; Vuister, G. W.; Zhu, G.; Pfeifer, J.; Bax, A. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 1995, 6, 277-293.
45. Goddard, T. D.; Kneller, D. G. Sparky 3.0. University of California, San Francisco, 2001.
46. Wuthrich, K. NMR of Proteins and Nucleic Acids; John Wiley: New York, 1986.
47. Lindahl, E.; Hess, B.; van der Spoel, D. GROMACS 3.0: A package for molecular simulation and trajectory analysis. J. Mol. Mod. 2001, 7, 306-317.
48. Berendsen, H. J. C.; Postma, J. P. M.; DiNola, A.; Haak, J. R. Molecular dynamics with coupling to an external bath. J. Chem. Phys. 1984, 81, 3684-3690.
49. Palczewski, K.; Kumasaka, T.; Hori, T.; Behnke, C. A.; Motoshima, H.; Fox, B. A.; Le Trong, I.; Teller, D. C.; Okada, T.; Stenkamp, R. E.; Yamamoto, M.; Miyano, M. Crystal structure of rhodopsin: A G protein-coupled receptor. Science 2000, 289, 739-745.